Medpage Today on MSN1mon
Real-World Data on the RSV Vaccine for Older Adults
In immunocompetent individuals, adjusted vaccine effectiveness reached 80% (95% CI 71-85) against RSV-associated ...
Labroots16d
A structurally stable, injectable, & immunocompetent human skin model to assess immunogenicity of therapeutic compounds (White Paper)
Key highlights include: Immunocompetent human skin models: Maintain viability and immune integrity for over 7 days, allowing for the detection of unwanted immune reactions earlier in the drug ...